KC
CDNA icon

Kepos Capital’s CareDx CDNA Stock Holding History

Kepos Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,931
Closed -$279K – 192
2019
Q4 		$279K Sell
12,931
-3,806
-23% -$87.3K 0.03% 286
2019
Q3 		$378K Buy
+16,737
New +$463K 0.04% 228

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kepos Capital's CDNA Position: Q1 2020 in Review

Kepos Capital sold out of CareDx (CDNA) in Q1 2020, closing a stake of 12,931 shares — an estimated $279K sold.

Kepos Capital first reported a position in CDNA in Q3 2019 and held it in 2 quarters. The position peaked at $378K in Q3 2019. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.

  • Kepos Capital reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
  • Kepos Capital sold 12,931 CareDx shares in Q1 2020, an estimated $279K.
  • Kepos Capital first reported a position in CareDx in Q3 2019 and held it in 2 quarters.
  • Kepos Capital's CareDx position peaked at $378K in Q3 2019.
  • 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.